Summit Therapeutics (SMMT) Return on Sales (2019 - 2023)
Summit Therapeutics (SMMT) reported Return on Sales of 26.83% for Q2 2023, down 2629.0% on a YoY basis from 1.06% in Q2 2022, and down 107.91% quarter-over-quarter from 12.9% in Q1 2023.
Summit Therapeutics (SMMT) Return on Sales (2019 - 2023) Analysis & Trends
Summit Therapeutics has reported Return on Sales for 5 years, with the latest figure at 26.83% in Q2 2023.
- For the quarter ending Q2 2023, Return on Sales fell 2629.0% year-over-year to 26.83%; the trailing twelve-month figure through Jun 2023 stood at 26.83% (down 2643.0% YoY), and the FY2022 full-year result was 1.12%, down 63.0% from the prior year.
- Return on Sales for Q2 2023 stood at 26.83%, down from 12.9% in the prior quarter.
- The five-year high for Return on Sales was 0.15% in Q3 2021, with the low at 26.83% in Q2 2023.
- Historically, Return on Sales has averaged 3.51% across 5 years, with a median of 0.9% in 2020.
- Annual changes were most pronounced in 2022 — Return on Sales jumped 374 bps — and 2023, when it sank 2629 bps.
- Summit Therapeutics' Return on Sales stood at 0.43% in 2019, then sank by 70 bps to 0.73% in 2020, then plunged by 48 bps to 1.08% in 2021, then grew by 5 bps to 1.02% in 2022, then tumbled by 2524 bps to 26.83% in 2023.
- The last three Return on Sales figures came in at 26.83% (Q2 2023), 12.9% (Q1 2023), and 1.02% (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Summit Therapeutics | 10.09 Bn | 9.99 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -26.83% |
| Mar 31, 2023 | -12.90% |
| Dec 31, 2022 | -1.02% |
| Sep 30, 2022 | -0.77% |
| Jun 30, 2022 | -0.54% |
| Mar 31, 2022 | -0.89% |
| Dec 31, 2021 | -1.08% |
| Sep 30, 2021 | -0.15% |
| Jun 30, 2021 | -4.28% |
| Mar 31, 2021 | -0.91% |
| Dec 31, 2020 | -0.73% |
| Sep 30, 2020 | -0.98% |
| Jun 30, 2020 | -0.90% |
| Mar 31, 2020 | -0.19% |
| Sep 30, 2019 | -0.43% |